RUSCONI, STEFANO

RUSCONI, STEFANO  

Dipartimento di Scienze Biomediche e Cliniche  

Mostra records
Risultati 1 - 20 di 343 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 2024 Andrea GiacomelliMaria Rita GismondoAndrea GoriSpinello AntinoriAngelo Valerio MarzanoGiulia MarchettiLorenzo BiasioliChiara FusettiSamuel LazzarinGiacomo PozzaStefano RusconiFederico SabainiFederica Salari + Article (author) -
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial 2024 Rusconi, Stefano + Article (author) -
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 2024 Marchetti, GiuliaRusconi, Stefano + Article (author) -
A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine 2024 Rusconi, Stefano + Article (author) -
Heavily Treatment-Experienced Persons Living with HIV Currently in Care in Italy: characteristics, Risk Factors, and Therapeutic Options - the ICONA Foundation Cohort study 2024 Rusconi, StefanoGori, AndreaMonforte, Antonella d'Arminio + Article (author) -
Investigating coping and stigma in people living with HIV through narrative medicine in the Italian multicentre non-interventional study DIAMANTE 2023 Rusconi, S + Article (author) -
Reduced probability of improving viro‐immunological state in subjects with vertical transmission of HIV reaching adult age: A multicenter retrospective cohort study 2023 Stefano RusconiVania Giacomet + Article (author) -
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA Study 2023 Antonella D'arminio monforteStefano RusconiSpinello AntinoriMatteo SalaLucia Taramasso + Article (author) -
An update on long-acting agents in HIV therapy 2023 Laura PezzatiGiada CanavesiStefano Rusconi Article (author) -
Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective Study 2023 Laura PezzatiFrancesco BassaniStefano Rusconi + Article (author) -
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: data from the ICONA cohort 2023 Stefano RusconiAndrea GiacomelliAntonella d'Arminio Monforte + Article (author) -
Pillars of long-term antiretroviral therapy success 2023 Taramasso, LuciaBandera, AlessandraD'Arminio Monforte, AntonellaGori, AndreaMarchetti, Giulia CarlaPerno, Carlo FedericoRusconi, Stefano + Article (author) -
Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial 2023 Rusconi, Stefano + Article (author) -
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 2023 Tincati, CamillaBono, ValeriaCannizzo, Elvira StefaniaTosi, DelfinaSavi, FedericaFalcinella, CamillaAugello, MatteoRusconi, StefanoBandera, AlessandraGori, AndreaMarchetti, Giulia + Article (author) -
Sexually transmitted infections in people with multidrug-resistant HIV 2023 Rusconi, Stefano + Article (author) -
Incident diabetes in course of antiretroviral therapy 2023 Taramasso, LuciaRusconi, Stefano + Article (author) -
Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome 2023 Rusconi, StefanoMistraletti, Giovanni + Article (author) -
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 2023 Rusconi S. + Article (author) -
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype 2023 Stefano Rusconi + Article (author) -
Effectiveness and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide therapy in an observational Italian cohort: the DIAMANTE study 2023 Stefano Rusconi + Article (author) -